Regeneron Pharmaceuticals (REGN) Receivables - Net (2009 - 2026)
Regeneron Pharmaceuticals' Receivables - Net came in at $6.57 billion for Q2 2026, up 17.0% from $5.61 billion a year earlier and up 14.6% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals' Receivables - Net was $5.74 billion, down 7.6% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $6.21 billion in FY2024 (+9.6%), $5.67 billion in FY2023 (+6.4%), $5.33 billion in FY2022 (-11.7%) and $6.04 billion in FY2021 (+46.7%).
- The Q2 2026 figure represents the highest quarterly Receivables - Net since Q2 2021.
- Year-over-year, Receivables - Net increased in five of the last eight quarters, with growth averaging 3.7%.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2021 (growth of 76.3%), and the weakest in Q2 2022 (a decline of 26.3%).
- Business Quant data shows REGN's Receivables - Net at $5.73 billion (Q1 2026), $5.74 billion (Q4 2025) and $5.69 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Bn |
| Mar 31, 2026 | 5.73 Bn |
| Dec 31, 2025 | 5.74 Bn |
| Sep 30, 2025 | 5.69 Bn |
| Jun 30, 2025 | 5.61 Bn |
| Mar 31, 2025 | 5.56 Bn |
| Dec 31, 2024 | 6.21 Bn |
| Sep 30, 2024 | 6.11 Bn |
| Jun 30, 2024 | 5.72 Bn |
| Mar 31, 2024 | 5.22 Bn |
| Dec 31, 2023 | 5.67 Bn |
| Sep 30, 2023 | 5.58 Bn |
| Jun 30, 2023 | 5.12 Bn |
| Mar 31, 2023 | 5.12 Bn |
| Dec 31, 2022 | 5.33 Bn |
| Sep 30, 2022 | 5.55 Bn |
| Jun 30, 2022 | 5.16 Bn |
| Mar 31, 2022 | 4.84 Bn |
| Dec 31, 2021 | 6.04 Bn |
| Sep 30, 2021 | 5.45 Bn |
API Access
Regeneron Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();